Summary.
In order to study whether the membrane hyperpolarization and firing inhibition caused by dopamine and levodopa on rat midbrain dopamine cells are affected by the inhibition of brain catechol-O-methyl-transferase (COMT), intracellular electrophysiological recordings were made from these neurons maintained in vitro. Here we report that a treatment of the cerebral tissue with tolcapone, a central and peripheral inhibitor of COMT, does not change the membrane responses of midbrain dopamine neurons to dopa-mine and levodopa. The lack of modification of the dopaminergic effects by tolcapone suggests that the pharmacological inhibition of intracerebral COMT does not have detectable action on dopamine neurotransmission. Therefore, the therapeutic action of tolcapone in Parkinson's disease, might be dependent on the reduction of COMT activity in the extracerebral tissue.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received May 1999; accepted June 7, 1999
Rights and permissions
About this article
Cite this article
Mercuri, N., Federici, M. & Bernardi, G. Inhibition of cathecol-O-methyltransferase (COMT) in the brain does not affect the action of dopamine and levodopa: an in vitro electrophysiological evidence from rat mesencephalic dopamine neurons. J Neural Transm 106, 1135–1140 (1999). https://doi.org/10.1007/s007020050229
Issue Date:
DOI: https://doi.org/10.1007/s007020050229